Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab

OBJECTIVE: To evaluate prospectively serological markers at baseline and during treatment in patients with rheumatoid arthritis (RA) initiating rituximab treatment, following failure of antitumour necrosis factor (TNF)-α therapy. METHODS: Patients with RA and healthy control subjects were recruited....

Descripción completa

Detalles Bibliográficos
Autores principales: Conigliaro, Paola, Triggianese, Paola, Chimenti, Maria Sole, Lucchetti, Ramona, Kroegler, Barbara, Perricone, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Immuno-Mediated Diseases and Treatment Immunogenicity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536544/
https://www.ncbi.nlm.nih.gov/pubmed/27683140
http://dx.doi.org/10.1177/0300060515593240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536544/
https://www.ncbi.nlm.nih.gov/pubmed/27683140
http://dx.doi.org/10.1177/0300060515593240

Ejemplares similares